“…With the exception of one Japanese study [27], less-active homozygous ADH1B has been demonstrated to increase the risk of esophageal cancer (OR = 1.6-8.2) [30] in various case-control studies of Japanese [5,21,23,24] ( Fig. 1), Chinese [28,29], Thai [46], and Central European populations [47], and in a prospective follow-up study in cancer-free Japanese alcoholics (hazard ratio = 2.0) [15]. The combination of inactive heterozygous ALDH2 and less-active homozygous ADH1B increased the risk of esophageal cancer (OR = 30-40) in a multiplicative fashion [5,24,29].…”